BioSpace News Archive

Pfizer Inc. and BioNTech SE announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 years of age and older.

CytoDyn Inc. announced Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, Nitya Ray, Ph.D., Chief Operating Officer and Chief Technology Officer and Christopher Recknor, M.D., Senior Executive VP of Clinical Operations of CytoDyn will host an investment community webcast on Tuesday, October 26, 2021.

MediciNova, Inc. announced an abstract entitled “MN-001 reduces triglycerides levels in hepatocytes by down-regulating fatty acid translocase/CD36 expression” has been selected for presentation at the 19th International Symposium on Atherosclerosis to be held October 24 - 27, 2021 in a hybrid format both online and onsite at the Kyoto International Conference Center in Kyoto, Japan.

Tetra Bio-Pharma Inc. announced that the European Medicines Agency Committee for Orphan Medicinal Products issued a positive opinion on the Company’s application for Orphan Drug Designation for its investigational medicine QIXLEEF™ as a potential treatment for Complex Regional Pain Syndrome, a chronic neuropathic pain condition.

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced financial results for the third quarter ended September 30, 2021.

VarmX has been awarded up to €17.5 million from the European Innovation Council Accelerator, subject to negotiation, to upscale and accelerate cost effective manufacturing of its lead compound, VMX-C001.

Fact.MR – A Market Research and Competitive Intelligence Provider: According to the latest Fact.MR analysis, the global ovarian cancer diagnostics market size was valued at US$ 1.3 Bn in 2020.

A cell bank refers to a facility that helps in the storage of cells of certain genome for future use in medicinal needs or in some product.

Orange Grove Bio, AlleyCorp and Alexandria Venture Investments, three industry leaders dedicated to the acceleration and growth of innovative healthcare and life science companies, announced the formation of a partnership program with Albert Einstein College of Medicine to support the development of novel therapeutics.